We are happy to announce that
​we are gearing up for another walk!

October 6th at 4pm with a walk around Burr Pond in Torrington Connecticut during Lakeridge's Fall Festival.
​

---

Join Our Fundraising-

 Seize the Ribbon Foundation for Bladder Cancer Research was founded in 2010 by the Miningham Family.
The foundation supports the work of
Drs. John Phillips and Senuki Konno at New York Medical College supporting innovative and progressive treatment of Bladder Cancer with research work in both molecular and herbal approaches to bladder cancer treatments.
 
 

Thank you for a great walk and all your support 5/5/18!  
 from the daughters of Robert Miningham and Dr. Phillips and Dr.Konno.

Seize The Ribbon has two doctors working to find bladder cancer destroying answers at New York Medical College in Valhalla, NY.

New York Medical College is the leading academic biomedical research center between New York City and the New York state capital of Albany. The College manages research and other sponsored programs, notably in the areas of cancer, cardiovascular disease, infectious diseases, kidney disease, the neurosciences, disaster medicine, and vaccine development.

2017_seize_the_ribbon_published_research_paperkonno2dg-bca_ijcto__pub_.pdf
File Size:	558 kb
File Type:	pdf

Download File

---

  Robert Miningham
  04/1942-4/2010
 Seize the Ribbon Foundation for
Bladder Cancer Research was started in his honor
and with his help in 2010.

Seize the Ribbon is a Bladder Cancer Research charitable organization that started with a symbol that was created by an artist for her dad to raise money .The ribbon was for the fight against bladder cancer and the hand was for his strength. Together symbolizing hope.

  He died on 4/15/10 but before this time he helped Seize the Ribbon form a plan for a foundation that would help fight Bladder Cancer.
When Seize the Ribbon became active in fundraising and decided to fund Bladder Cancer Research they found Dr. Phillips (who had been part of Robert’s Urology  team) and Dr. Konno working on bladder cancer research in NY Medical College. Their work was/ is the innovative and progressive treatment of Bladder Cancer with research work in both molecular and herbal approaches to bladder cancer treatments.
A mission was formed not long after Robert’s death that involved family and friends working without compensation to raise money each year to continue to support the doctors in their ground breaking research.
Now we are proud to say in 2018 that we are growing as a 501c3 Charitable Organization that has since 2010 raised  $139,900.and Every penny raised still supports Bladder Cancer Research at NYMC in Vallaha NY.

We are proud of how far we have come in such a short time! Since 2010 we have continued to grow.

-We are a 501(c)3 foundation

-We are a registered New York Charity

- New York Medical School has set up an account for ‘Seize the Ribbon’. This allows us the ability to directly fund Bladder Cancer Research.

-We have created  Annual fundraisers- 
Walk-a-thons  and the Harvest party in October. both are used for education as well.

-Seize the Ribbon also sponsors local school fundraisers.

-In December of 2010 we donated $5,000, in December of 2011 we have reached our $10,000 goal. In 2012 we donated $14,500, and in 2013 we donated $20,000. In  2014 we raised and donated $20,000.$25,400 in 2015.2016 was $30,000! 2017 was $15,000..

-Our new goal for 2018 is to donate $35,000 to Bladder Cancer Research.

Other sources of fundraising we have-

-We have t-Shirts, hats and jewelry with our symbol for anyone who is fighting cancer and the ability to color the ribbon for your fight.  

-Seize the Ribbon is also available on Facebook! We share our stories and news.

Most important is that our foundation is run by family and friends with donated time.

 

Seen here is the research team of Dr. Konno (Left), Dr. Valera (middle) Dr. Philipps (right

Dr. John Phillips 
Bladder Cancer Research
 MD, FACS
Bladder cancer research of Nano-particle technology to improve effectiveness
of intravesical chemotherapy delivery
                             

 Dr.Sensuke Konno, Ph.D
Bladder cancer research of Pharmacology of
Mitake/Poria Mushroom combined with Vitamin C

  We would first like to thank all of our supporters from last year and tell you that because of your donations to Seize the Ribbon, we have been able to support innovation and progress in the treatment of bladder cancer, a disease known for its great toll on quality of life, life expectancy, and cost of therapy. Your efforts have supported Drs. John Phillips and Senuki Konno at New York Medical College who continue the groups’ work in both molecular and herbal approaches to bladder cancer treatments. A recent advance was achieved by the group's post-doctoral resident, Dr. Vladimir Valera, who presented his findings on Seize the Ribbon-supported research at last year’s Society of Urologic Oncology in Washington DC. Dr. Valera’s work was awarded first prize beating out researches from Harvard, Memorial Sloane Kettering, and John Hopkins. The research team is also working on a combination approach of Vitamin C and Mitake mushroom exacts which are shown to be safe for human consumption. A clinical trial for early bladder cancers is underway and interested participants can contact Dr. Konno or Dr. Phillips at 914 594 2440 .We want to emphasize that while we focus on Bladder Cancer, Seize the Ribbon supported research dollars from you go beyond a specific cancer and may aid in finding answers to help fight other cancers as well.

News from 11/29/17-Thanks to crucial support from Seize the Ribbon, much has happened with the progress in our research program against bladder cancer. We have a unique genetic mouse model of bladder cancer that we have studied showing the relationship between the expression of a defective gene, Uroplakin, and the development of early bladder cancers. We also have been able to determine the expression level of the Uroplakin gene to identify mouse candidates for our new nanoparticle drug trial. One drug, under development by a partner research firm, Phosphorex, will be used to attack the bladder cancers in genetically affected mice. A second drug, under partnership with Johns Hopkins, will be used to attack bladder cancers that do not specifically express mutant Uroplakin gene. By our next report, we should have rather innovative data as a basis for translational trials. With gratitude and great appreciation John

News From 4/9/16-
Dr. Phillips talked about exciting new developments during the walkathon-

The bladder has an inner lining well suited as a reservoir. The bladder expands at low pressure, empties while protecting the kidneys from short increases in pressure, and the bladder is nearly impermeable so foreign substances are not absorbed. The impermeability decreases the effectiveness of chemotherapy placed directly into the bladder. Most bladder cancers could be treated if chemotherapy were more effective. We established a collaboration with researchers from NYU and from Qualiber, a tech start up from Chapel Hill, in which chemotherapy is delivered into the bladder packed within tiny nanoparticles. The nanoparticles attach to the bladder wall and are absorbed easily. Then, the packaging or envelope layer of the nanoparticle dissolves releasing the chemotherapy. Our plan, using Seize the Ribbon support, is to test nanoparticle effectiveness in treating bladder cancers in an engineered mouse that develops bladder cancers early in life. Such work is critical to demonstrating effectiveness and safety before moving ahead with any clinical trial
    News from 2015-

1. Dr. Konno published his work on bladder cancer and the anti-cancer effect of herbal drugs in an important journal, citing "Seize the Ribbon" support in the acknowledgements.

2. Dr. Valera submitted his research on a new drug in bladder cancer at last weeks' Society of Urologic Oncology meeting in Washington.  There were 200 abstracts submitted and Vladimir's work was chosen as 1st prize for his session.   Besides Vladimir, the other 6 awardees were from the Mayo Clinic, Memorial Sloane Kettering, Cornell, Johns Hopkins, and the University of Georgia.  "Pretty good company". 

From 2014-

Dr.Philips was explaining while walking together during Seize the Ribbon walk-a-thon ...Here is a short synopsis of the current in-vivo work: 

Extracts of maitake mushrooms called the maitake D-fraction (PDF) appear to synergize with vitamin C (VC) in producing an anti-tumor effect. We are currently determining whether there is a tissue- and dose-specific effect of the PDF/VC combination in a controlled murine model. A Phase III trial is being established to determine whether PDF/VC decreases the recurrence and/or progression rate of superficial bladder cancers. The target of PDF/VC appears to be cell cycle regulatory proteins, p21 and p53. We aim to determine whether tumor expression of these two molecules, or the expression of Fibroblast Growth Factor Receptor-III (FGFR-III) predicts responsiveness to PDF/VC. 

Extracts of maitake mushrooms called the maitake D-fraction (PDF) appear to synergize with vitamin C (VC) in producing an anti-tumor effect. We are currently determining whether there is a tissue- and dose-specific effect of the PDF/VC combination in a controlled murine model. A Phase III trial is being established to determine whether PDF/VC decreases the recurrence and/or progression rate of superficial bladder cancers. The target of PDF/VC appears to be cell cycle regulatory proteins, p21 and p53. We aim to determine whether tumor expression of these two molecules, or the expression of Fibroblast Growth Factor Receptor-III (FGFR-III) predicts responsiveness to PDF/VC.

Did you know:Over 81,000 will be diagnosed with bladder cancer in a year
-It is the eighth most common cause of cancer deaths-
 Men are 4 times as likely to be diagnosed than females!

Signs-Blood in the urine, Painful urination, Urgent need to urinate, Feeling the need but not able to urinate
Symptoms-Abdominal pain, Fatigue, Lower back pain, Appetite or weight loss
 
Risk Factors-Smoking, Race, gender and age, Medical history of cancer, Chronic bladder inflammation

*5 year survival rate tells you what percent of people live at least 5 years after cancer is found. Bladder cancer has a 77% rate.
So catch it now! 
 

Thank you to our sponsors

Wingswept Farm